HSA — authorised 4 June 1965
- Marketing authorisation holder: ADVANCE BIOFACTURES
- Status: likely_approved
🇸🇬 Xiaflex in Singapore
HSA authorised Xiaflex on 4 June 1965
Marketing authorisation
Xiaflex in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in Singapore
Frequently asked questions
Is Xiaflex approved in Singapore?
Yes. HSA authorised it on 4 June 1965.
Who is the marketing authorisation holder for Xiaflex in Singapore?
ADVANCE BIOFACTURES holds the Singaporean marketing authorisation.